New York, N.Y., and Princeton, N.J. (March 27, 2025)—With a mission to understand how nutrition and metabolism impact the body’s ability to control cancer, four leading research institutions have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment. The initiative connects world-class experts from Princeton University, The Rockefeller University, Weill Cornell Medicine and the Ludwig Institute for Cancer Research to enhance a therapeutic strategy known as immunotherapy that harnesses a patient’s own immune cells to treat cancer. Immunotherapy holds much promise, but its effectiveness varies in different people and against different types of cancer.
The Weill Cancer Hub East was established with a transformational $50 million gift from the Weill Family Foundation, directed by visionary benefactors Joan and Sanford I. Weill, and matched with philanthropy from each partner institution that together will total more than $125 million. The initiative seeks to break down institutional barriers and unite top experts in cancer biology, cancer clinical trials, immunology, nutrition and metabolism to drive pioneering, cross-field collaboration that pushes the boundaries of scientific discovery.